| Company Name: |
Lynnchem
|
| Tel: |
86-(0)29-85992781 17792393971 |
| Email: |
info@lynnchem.com |
| Products Intro: |
Product Name:STEFFIMYCIN B
CAS:54526-94-2
Purity:>99% by HPLC Package:1mg;5mg
|
| Company Name: |
Novachemistry
|
| Tel: |
44-20819178-90 02081917890 |
| Email: |
info@novachemistry.com |
| Products Intro: |
Product Name:Steffimycin B
CAS:54526-94-2
Purity:>99% by HPLC Package:1mg;5mg
|
| Company Name: |
Shanghai Hongye Biotechnology Co. Ltd
|
| Tel: |
400-9205774 |
| Email: |
sales@glpbio.cn |
| Products Intro: |
Product Name:Steffimycin B
CAS:54526-94-2
Purity:>98% Package:1mg;10mg;50mg;100mg;
|
|
| | STEFFIMYCIN B Basic information |
| Product Name: | STEFFIMYCIN B | | Synonyms: | STEFFIMYCIN B;1,6,11(2h)-naphthacenetrione,4-((6-deoxy-2,4-di-o-methyl-alpha-l-mannopyranosy;5,7-trihydroxy-3,9-dimethoxy-2-methyl-l)oxy)-4-dihydro-2;u40615;4-(2-O,4-O-Dimethyl-α-L-rhamnopyranosyloxy)-3,4-dihydro-2,5,7-trihydroxy-3,9-dimethoxy-2-methyl-1,6,11(2H)-naphthacenetrione;4-[(2-O,4-O-Dimethyl-6-deoxy-α-L-mannopyranosyl)oxy]-3,4-dihydro-2,5,7-trihydroxy-3,9-dimethoxy-2-methyl-1,6,11(2H)-naphthacenetrione;Steffimycin 4'-methyl ether;1,6,11(2H)-Naphthacenetrione, 4-((6-deoxy-2,4-di-o-methyl-alpha-L-mannopyranosyl)oxy)-3,4-dihydro-2,5,7-trihydroxy-3,9-dimethoxy-2-methyl- | | CAS: | 54526-94-2 | | MF: | C29H32O13 | | MW: | 588.56 | | EINECS: | | | Product Categories: | | | Mol File: | 54526-94-2.mol |  |
| | STEFFIMYCIN B Chemical Properties |
| Boiling point | 801.2±65.0 °C(Predicted) | | density | 1.52±0.1 g/cm3(Predicted) | | storage temp. | Store at -20°C | | solubility | DMF: soluble; DMSO: soluble; Ethanol: soluble; Methanol: soluble | | form | A lyophilisate | | pka | 5.09±0.70(Predicted) |
| | STEFFIMYCIN B Usage And Synthesis |
| Uses | Steffimycin B is an anthracycline metabolite isolated from a Streptomyces sp., with antibacterial and antineoplastic properties. Crystallographic studies of binding to DNA suggest that it has a higher CpG base sequence specificity over the TpA step, similar to that of daunorubicin and nogalamycin. A close analogue was shown to be active against ras oncogene-expressed cells. |
| | STEFFIMYCIN B Preparation Products And Raw materials |
|